HTG Molecular Diagnostics Inc (HTGM)-Medical Equipment-Deals and Alliances Profile

HTG Molecular Diagnostics Inc (HTGM)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME245699D
  • |
  • Pages: 47
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

HTG Molecular Diagnostics Inc (HTG) is an information technology company that provides molecular technology solutions. The company offers products including HTG edge system, HTG edgeseq reagents, HTG edge system, HTG edgeseq oncology biomarker panel assay, and others. It develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. HTG also provides endogenous control array, custom array development, qSelect miRNA gene list, qSelect mRNA gene list, qDiscovery miRNA Version 16, clinical trial support and ingenuity IPA data analysis services. The company provides services to biomarker discovery and companion diagnostic developers. HTG is headquartered in Tucson, Arizona, the US.

HTG Molecular Diagnostics Inc (HTGM)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

HTG Molecular Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

HTG Molecular Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

HTG Molecular Diagnostics Inc, Medical Equipment, Deal Details 12

Venture Financing 12

HTG Molecular Diagnostics Raises USD18 Million in Venture Financing 12

HTG Molecular Diagnostics to Raise USD0.8 Million in Venture Financing 12

HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 13

HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing 14

Partnerships 15

HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 15

HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 16

HTG Molecular Diagnostics Enters into Research Agreement with Instituto Valenciano de Oncologia 17

HTG Molecular Diagnostics Enters into Research Agreement with Centre Leon Berard 17

HTG Molecular Diagnostics Enters into Co-Development Agreement with Qiagen Manchester 18

HTG Molecular Diagnostics Enters into Agreement with Merck 19

HTG Molecular Diagnostics Enters into Research Agreement with Bristol-Myers Squibb 19

HTG Molecular Diagnostics Enters into Distribution Agreement with Gamidor Diagnostics 20

HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 21

HTG Molecular Diagnostics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 22

HTG Molecular Diagnostics Amends its Agreement with Illumina to Develop IVD Kits for Sequencing Tests 22

HTG Molecular Diagnostics Enters Into Development Agreement With OvaGene Oncology 23

Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 24

HTG Molecular Diagnostics Enters Into Co-Marketing Agreement With John Wayne Cancer Institute 25

HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis 26

Equity Offering 27

HTG Molecular Diagnostics to Raise up to USD20 Million in Public Offering of Shares 27

HTG Molecular Diagnostics Prices IPO for USD50 Million 28

HTG Molecular Diagnostics Inc-Key Competitors 30

Key Employees 31

Locations And Subsidiaries 32

Head Office 32

Recent Developments 33

Financial Announcements 33

May 15, 2017: HTG Molecular Diagnostics Reports First Quarter 2017 Results 33

Mar 23, 2017: HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results 34

Nov 14, 2016: HTG Molecular Diagnostics Reports Third Quarter 2016 Results 35

Aug 09, 2016: HTG Molecular Diagnostics Reports Second Quarter 2016 Results 36

May 12, 2016: HTG Molecular Diagnostics Reports First Quarter 2016 Results 37

Mar 24, 2016: HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2015 Results 38

Corporate Communications 39

Mar 07, 2017: HTG Molecular Diagnostics Appoints New Chair of the Board of Directors 39

Aug 29, 2016: Dr. Ann Hanham Joins HTG Molecular Diagnostics' Board of Directors 40

Jun 20, 2016: HTG Molecular Appoints New Vice President of North American Capital Sales for the HTG EdgeSeq Platform 41

May 03, 2016: Don Hardison Joins the Board of Directors for HTG Molecular Diagnostics 42

Feb 16, 2016: HTG Molecular Diagnostics Establishes Immuno-Oncology Scientific Advisory Board 43

Product News 44

May 04, 2017: HTG Molecular Diagnostics Introduces HTG EdgeSeq PATH Assay to Launch in Second Quarter 2017 44

Other Significant Developments 45

Feb 27, 2017: HTG Molecular Diagnostics Unveils New Direct-Target Sequencing Chemistry to Launch in First Quarter 2017 45

Jun 23, 2016: HTG Molecular Diagnostics Announces VERI/O Laboratory Service 46

Appendix 47

Methodology 47

About GlobalData 47

Contact Us 47

Disclaimer 47

List of Figures

HTG Molecular Diagnostics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

HTG Molecular Diagnostics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

HTG Molecular Diagnostics Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

HTG Molecular Diagnostics Inc, Medical Equipment, Key Facts, 2015 1

HTG Molecular Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

HTG Molecular Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

HTG Molecular Diagnostics Inc, Deals By Market, 2011 to YTD 2017 9

HTG Molecular Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

HTG Molecular Diagnostics Raises USD18 Million in Venture Financing 12

HTG Molecular Diagnostics to Raise USD0.8 Million in Venture Financing 12

HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 13

HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing 14

HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 15

HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 16

HTG Molecular Diagnostics Enters into Research Agreement with Instituto Valenciano de Oncologia 17

HTG Molecular Diagnostics Enters into Research Agreement with Centre Leon Berard 17

HTG Molecular Diagnostics Enters into Co-Development Agreement with Qiagen Manchester 18

HTG Molecular Diagnostics Enters into Agreement with Merck 19

HTG Molecular Diagnostics Enters into Research Agreement with Bristol-Myers Squibb 19

HTG Molecular Diagnostics Enters into Distribution Agreement with Gamidor Diagnostics 20

HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 21

HTG Molecular Diagnostics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 22

HTG Molecular Diagnostics Amends its Agreement with Illumina to Develop IVD Kits for Sequencing Tests 22

HTG Molecular Diagnostics Enters Into Development Agreement With OvaGene Oncology 23

Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 24

HTG Molecular Diagnostics Enters Into Co-Marketing Agreement With John Wayne Cancer Institute 25

HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis 26

HTG Molecular Diagnostics to Raise up to USD20 Million in Public Offering of Shares 27

HTG Molecular Diagnostics Prices IPO for USD50 Million 28

HTG Molecular Diagnostics Inc, Key Competitors 30

HTG Molecular Diagnostics Inc, Key Employees 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

HTG Molecular Diagnostics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16608
Site License
USD 500 INR 33215
Corporate User License
USD 750 INR 49823

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com